Back to results

University of Illinois at Urbana-Champaign

Lithium-Carbonate as a Protectant Against Chemotherapy-Induced Myelosuppression

Abstract

dc:description

Lithium carbonate has been used as an adjunct to cancer chemotherapy to lessen the dose-limiting myelosuppressive effects of several anti-cancer drugs. Its mechanism is unknown, but several possible sites of action have been considered. Lithium causes a neutrophilia and may protect the bone marrow against the toxic effects of myelosuppressive drugs.

Degree

thesis:*
Name thesis:degree_name
Ph.D.
Level thesis:degree_level
Dissertation
Discipline thesis:degree_discipline
Veterinary Medical Science
Grantor
University of Illinois at Urbana-Champaign
Year dc:date
2014

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Rosenthal, Robert Charles

Subjects

dc:subject × 2

Identifiers

dc:identifier.*
Identifier
(UMI)AAI8521871
OAI identifier oai:identifier
oai:www.ideals.illinois.edu:2142/71324

Chain of custody

source
Harvested from
University of Illinois - Urbana-Champaign
Base URL
www.ideals.illinois.edu/oai-pmh
Last updated
2026-07-22
Source record
OAI-PMH GetRecord
citation

Rosenthal, Robert Charles. Lithium-Carbonate as a Protectant Against Chemotherapy-Induced Myelosuppression. Dissertation thesis, University of Illinois at Urbana-Champaign, 2014. http://hdl.handle.net/2142/71324